Nov. 29, 2017—EKF Diagnostics announced that its Stanbio Chemistry Procalcitonin LiquiColor assay has been FDA cleared and validated for use on Beckman AU 480, 680, and 5800 clinical chemistry analyzers. EKF confirms the immediate availability of a user defined application for running this 10-minute test for bacterial infection and sepsis on these analyzers.
EKF’s PCT test is designed to be used on an open channel of most main clinical chemistry analyzers, including Roche Cobas, Abbott Architect, and Hitachi systems. The availability of the user defined application on Beckman AU analyzers further increases the breadth of application of the LiquiColor PCT assay.
“The news regarding the FDA clearance and Beckman AU analyzer validated application for the PCT LiquiColor assay will bolster trust in the quality and reliability of our product. Having EKF’s PCT assay validated on Beckman AU chemistry analyzers allows us to provide a competitive alternative product for hospital labs and should open up new markets and opportunities for us to support improved and early detection of sepsis,” Trevor McCarthy, sales manager, EKF central laboratory products, Europe, Middle East, Africa, and Asia Pacific, said in a statement.